Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| RxSight, Inc.RXST · Entity 1226 | See remarks | September 15, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
RxSight, Inc.
Report date September 15, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 235,516 |
Reported balance
After 2026-09-15 transaction · row 1
1 source rowRow 1 · 2026-09-15 · Exercise / conversion · Acquired 35,168 · Balance 235,516 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.34 · Expires 2027-03-14 | Direct | 0 |
Reported balance
After 2026-09-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-15 · Exercise / conversion · Disposed 35,168 · Balance 0 F2: The shares subject to the option were fully vested and exercisable. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 299,978 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 299,978 F1: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. |
| Common StockSEC Table I · non-derivative | IndirectBy spouse | 925 |
Reported balance
Holding disclosure · report date 2026-09-15 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 925 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee.
F2: The shares subject to the option were fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 16, 2026 20:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 35,168 | $0.00 Strike: $4.34 | $0.00 |
DisclosureSEC source: 0001295814-26-000004 · form4-09162026_080936.xml · derivative · entry 4 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,168 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option were fully vested and exercisable. Read SEC document |
| September 15, 2026 Filed Sep 16, 2026 20:25 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 35,168 | $4.34 | $152,629.12 |
DisclosureSEC source: 0001295814-26-000004 · form4-09162026_080936.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 93,984 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 10 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,984 Underlying: Common Stock · 93,984 shares Expires 2033-09-04 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F12 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 35,244 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 35,244 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 58,740 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 32,258 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 9 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,258 Underlying: Common Stock · 32,258 shares Expires 2033-09-04 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F11 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 16,129 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 16,129 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 16,129 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 59,483 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 8 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,483 Underlying: Common Stock · 59,483 shares Expires 2033-09-04 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F10 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 37,177 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 37,177 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 22,306 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 82,608 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 7 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,608 Underlying: Common Stock · 82,608 shares Expires 2033-09-04 F3 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F9 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the 70,560 shares subject to the option will vest on February 28, 2027 and the remaining 75% of the 70,560 shares subject to the option will vest on August 31, 2027. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one twenty-fourth (1/24th) of the 12,048 shares subject to the option will vest on February 28, 2027 and in equal monthly installments thereafter. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 65,742 | Not disclosed Strike: $6.38 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 6 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,742 Underlying: Common Stock · 65,742 shares Expires 2033-09-04 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F8 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, 25% of the shares subject to the option will vest on February 28, 2027 and the remaining 75% of the shares subject to the option will vest on August 31, 2027. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 125,000 | Not disclosed Strike: $28.21 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 5 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 125,000 shares Expires 2035-02-26 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. F7 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | Not disclosed Strike: $46.24 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 4 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2034-08-06 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F6 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 92,200 | Not disclosed Strike: $56.07 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 3 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 92,200 shares Expires 2034-03-03 F5 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.55:1 basis with a post-exchange exercise price of $6.375 per share. F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock Option (right to buy) · Derivative | 95,000 | Not disclosed Strike: $14.95 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 2 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 95,000 shares Expires 2033-03-09 F3 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.15:1 basis with a post-exchange exercise price of $6.375 per share. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. Read SEC document |
| September 05, 2026 Filed Sep 10, 2026 00:55 UTC | RxSight, Inc. RXST · Entity 1226 | Disposition to issuerStock option (right to buy) · Derivative | 87,437 | Not disclosed Strike: $16.00 | Not disclosed |
DisclosureSEC source: 0001193125-26-386840 · ownership.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,437 shares Expires 2031-07-30 F1 · price: On September 5, 2026, in connection with the Issuer's option exchange program, the Issuer exchanged the Reporting Person's outstanding option on a 1.33:1 basis with a post-exchange exercise price of $6.375 per share. Read SEC document |
| September 02, 2026 Filed Sep 3, 2026 01:33 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 2,041 | $6.96 | $14,205.36 |
DisclosureSEC source: 0001193125-26-380710 · ownership.xml · nonDerivative · entry 2 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,348 F3 · kind: Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person. Read SEC document |
| August 31, 2026 Filed Sep 3, 2026 01:33 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionRestricted Stock Unit · Derivative | 5,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-380710 · ownership.xml · derivative · entry 5 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,848 Underlying: Common Stock · 5,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F5 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. F5 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. Read SEC document |
| August 31, 2026 Filed Sep 3, 2026 01:33 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 5,370 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-380710 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Includes 1,668 shares of Common Stock acquired October 31, 2025 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 27, 2026 Filed Mar 4, 2026 01:20 UTC | RxSight, Inc. RXST · Entity 1226 | GrantRestricted Stock Unit · Derivative | 32,218 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-089489 · ownership.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,218 Underlying: Common Stock · 32,218 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan (the "Plan")) through each applicable date, one-sixth (1/6th) of the RSUs subject to the award shall vest on the first Trading Day (as defined in the Plan) on or after each of August 31, 2026, February 28, 2027, August 31, 2027, February 28, 2028, August 31, 2028 and February 28, 2029. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 22:18 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionStock Option (right to buy) · Derivative | 188,002 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0000950170-25-081185 · ownership.xml · derivative · entry 4 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 188,002 shares Expires 2025-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Form 3 filed July 29, 2021 incorrectly reflected 187,998 shares. F3 · derivative.underlying_shares: Form 3 filed July 29, 2021 incorrectly reflected 187,998 shares. Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 22:18 UTC | RxSight, Inc. RXST · Entity 1226 | Exercise / conversionCommon Stock | 188,002 | $3.93 | $738,847.86 |
DisclosureSEC source: 0000950170-25-081185 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,121 shares of Common Stock acquired April 30, 2024 under the Issuer's 2021 Employee Stock Purchase Plan. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 01:06 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $28.21 | $0.00 |
DisclosureSEC source: 0000950170-25-029399 · ownership.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-02-26 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 27, 2025. Read SEC document |
| August 07, 2024 Filed Aug 8, 2024 20:18 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $46.24 | $0.00 |
DisclosureSEC source: 0000950170-24-094027 · ownership.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-08-06 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean August 7, 2024. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 21:26 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 92,200 | $0.00 Strike: $56.07 | $0.00 |
DisclosureSEC source: 0000950170-24-027188 · ownership.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,200 Underlying: Common Stock · 92,200 shares Expires 2034-03-03 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 4, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:47 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 10,000 | $50.00 | $500,004.00 |
DisclosureSEC source: 0000950170-24-010564 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 299,978 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $50.00 to $50.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 00:50 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 10,000 | $48.00 | $480,006.00 |
DisclosureSEC source: 0000950170-24-006199 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 309,978 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $48.00 to $48.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 09, 2024 Filed Jan 10, 2024 22:28 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 10,000 | $46.00 | $460,000.00 |
DisclosureSEC source: 0000950170-24-003681 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 319,978 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| January 08, 2024 Filed Jan 9, 2024 21:12 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 10,000 | $42.00 | $420,000.00 |
DisclosureSEC source: 0000950170-24-003342 · ownership.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 329,978 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 21:11 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 1,285 | $40.00 | $51,400.00 |
DisclosureSEC source: 0001209191-23-059682 · doc4.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 339,978 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| December 15, 2023 Filed Dec 20, 2023 01:14 UTC | RxSight, Inc. RXST · Entity 1226 | SaleCommon Stock | 8,715 | $40.01 | $348,710.68 |
DisclosureSEC source: 0001209191-23-059280 · doc4.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Indirect · See footnote Disclosed balance after: 341,263 F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 12, 2023 by the Reporting Person. F2 · price: Represents the weighted average share price of an aggregate total of 8,715 shares sold in the price range of $40.00 to $40.075 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · balance_after: Includes 31,250 shares reported as directly held by the Reporting Person in previous Form 4 filings. F4 · ownership.nature: Shares held by the EJW Living Trust, for which the Reporting Person serves as trustee. Read SEC document |
| March 09, 2023 Filed Mar 10, 2023 21:11 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock Option (right to buy) · Derivative | 95,000 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001209191-23-017796 · doc4.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 95,000 shares Expires 2033-03-09 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean March 9, 2023. Read SEC document |
| August 05, 2021 Filed Aug 7, 2021 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 9 | $14.90 | $134.10 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 5 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 925 Read SEC document |
| August 04, 2021 Filed Aug 7, 2021 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 615 | $16.25 | $9,993.93 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 4 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 916 F3 · price: Represents the weighted average share price of an aggregate total of 615 shares purchased in the price range of $16.00 to $16.40 by the Reporting Person's fiance. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:34 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 31,250 | $16.00 | $500,000.00 |
DisclosureSEC source: 0000899243-21-031821 · doc4.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,250 Read SEC document |
| August 03, 2021 Filed Aug 7, 2021 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 1 | $17.03 | $17.03 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 3 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 301 Read SEC document |
| August 02, 2021 Filed Aug 7, 2021 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 90 | $17.04 | $1,533.30 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 2 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 300 F2 · price: Represents the weighted average share price of an aggregate total of 90 shares purchased in the price range of $16.45 to $17.05 by the Reporting Person's fiance. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| July 31, 2021 Filed Aug 3, 2021 00:35 UTC | RxSight, Inc. RXST · Entity 1226 | GrantStock option (right to buy) · Derivative | 87,437 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0000899243-21-031121 · doc4.xml · derivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,437 Underlying: Common Stock · 87,437 shares Expires 2031-07-31 F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean July 30, 2021. Read SEC document |
| July 30, 2021 Filed Aug 7, 2021 00:53 UTC | RxSight, Inc. RXST · Entity 1226 | PurchaseCommon Stock | 210 | $16.94 | $3,556.92 |
DisclosureSEC source: 0000899243-21-031996 · doc4.xml · nonDerivative · entry 1 Weinberg Eric · CIK 0001295814 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By fiance Disclosed balance after: 210 F1 · price: Represents the weighted average share price of an aggregate total of 210 shares purchased in the price range of $16.90 to $16.94 by the Reporting Person's fiance. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.